Recommended Topic Related To:

Flunisolide Nasal Solution

"The U.S. Food and Drug Administration recently approved Oralair to treat allergic rhinitis (hay fever) with or without conjunctivitis (eye inflammation) that is induced by certain grass pollens in people ages 10 through 65 years. Oralair is the f"...

Flunisolide Nasal Solution

Flunisolide Nasal Solution Side Effects Center

Medical Editor: John P. Cunha, DO, FACOEP

Flunisolide nasal solution is used to manage the nasal symptoms of seasonal or perennial rhinitis. It is an anti-inflammatory glucocorticosteroid. This medication is available in generic form. Common side effects include aftertaste, nasal burning and stinging.

For adults, the recommended starting dose of flunisolide nasal solution is 2 sprays (58 mcg) in each nostril 2 times a day (total dose 232 mcg/day). For pediatric patients 6 to 14 years of age, the recommended starting dose is one spray (29 mcg) in each nostril 3 times a day (total dose 174 mcg/day) or 2 sprays (58 mcg) in each nostril 2 times a day (total dose 232 mcg/day). Flunisolide nasal solution may interact with other drugs. Tell your doctor all medications and supplements you use. During pregnancy, flunisolide nasal solution should be used only if prescribed. It is unknown if this drug passes into breast milk. Consult your doctor before breastfeeding.

Our Flunisolide Nasal Solution Side Effects Drug Center provides a comprehensive view of available drug information on the potential side effects when taking this medication.

This is not a complete list of side effects and others may occur. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.

What is Prescribing information?

The FDA package insert formatted in easy-to-find categories for health professionals and clinicians.

Flunisolide Nasal Solution FDA Prescribing Information: Side Effects
(Adverse Reactions)

SIDE EFFECTS

The adverse events rates listed below are based on symptoms spontaneously reported in multidose controlled clinical trials in comparing flunisolide nasal solution (29 mcg per spray) and flunisolide nasal solution (flunisolide nasal spray .025%) (25 mcg per spray) for treatment of allergic rhinitis. In patients receiving flunisolide nasal solution (flunisolide nasal spray .025%) the most common adverse events were transient aftertaste (17%) and transient nasal burning and stinging (13%). These symptoms did not usually interfere with treatment.

Adverse Event Rates for Flunisolide Nasal Solution (flunisolide nasal spray .025%) (29 mcg per spray)

Incidence Greater than 1% (probably casually related)

Respiratory: Nasal burning/stinging (13%), epistaxis*, nasal dryness, pharyngitis, cough increased

Gastrointestinal: Nausea

Special Senses: Aftertaste (17%)

Incidence 1% or Less (probably casually related)

Respiratory: Hoarseness

Special Senses: Abnormal sense of smell

Incidence 1% or Less (casual relationship unknown)+

Respiratory: Sinusitis

Adverse Event Rates for Flunisolide Nasal Solution (flunisolide nasal spray .025%) (25 mcg per spray)

Incidence Greater than 1% (probably casually related)

Respiratory: Nasal burning/stinging (44%), epistaxis*, nasal dryness*, pharyngitis*, cough increased

Gastrointestinal: Nausea

Special Senses: Aftertaste (8%)

Incidence 1% or Less (probably casually related)

Respiratory: Hoarseness, nasal ulcer

Incidence 1% or Less (casual relationship unknown)+

Respiratory: Sinusitis

* Incidence of reported reaction between 3% and 9%. Those reactions occurring in less than 3% of the patients are unmarked.
+ Reactions occurred under circumstances where the casual relationship has not been clearly established; they are presented as alerting information for physicians.

Cases of growth suppression have been reported for intranasal corticosteroids (including flunisolide nasal solution) (see PRECAUTIONS, Pediatric Use section).

Read the entire FDA prescribing information for Flunisolide Nasal Solution (Flunisolide Nasal Spray .025%) »

A A A

Report Problems to the Food and Drug Administration

 

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.


Allergies & Asthma

Improve treatments & prevent attacks.


NIH talks about Ebola on WebMD